Peregrine Pharmaceuticals lost nearly a quarter of its value Thursday after developer of cancer medications was unable to meaningfully extend the lives of lung-cancer patients in a Phase 2 trial.

Billions of dollars could be saved in medical costs if patients took the medications prescribed to them by doctors, and those patients could save billions more if they opted for generic treatments instead ...

A report from the Organization for Economic Cooperation and Development suggests that the increase in medical costs in many countries in the coming decades is likely to be even steeper than in the United ...

By David Morgan WASHINGTON, June 27 (Reuters) - The biggest operator of Blue Cross Blue Shield health plans is teaming up with the largest U.S. Spanish-language media network to explain Obamacare to Hispanics ...

Microsoft announced support for 3D printing with Windows 8.1, making it the first operating system to do so.

Based in New York City, New York, Ventrus Biosciences, Inc. ( VTUS ), is a development stage specialty pharmaceutical company focused on late stage drugs for gastrointestinal disorders. The 40M market ...

U.S. Authorities Shut Down 1,600 Fake Pharmacy Websites

Montana Insurance Commissioner Monica Lindeen has approved an Illinois company's plans to buy Blue Cross and Blue Shield of Montana. Blue Cross is Montana's largest private health insurer with about 250,000 ...

Accuray announced that U.S.-based Tulsa Cancer Institute is the first to use its latest TomoHDA System to treat cancer patients.

Resverlogix Corp. sank the most on record after saying its drug to fight thickening of the arteries failed to meet its primary target in a phase 2 clinical trial.

Mergers and Acquisitions Roundup: 4 Merger and Acquisitions Stock Stories Making a Buzz Today

In a health care decision giving hope to opponents of the federal birth-control coverage mandate, a federal appeals court ruled Thursday that Hobby Lobby stores won't have to start paying millions of dollars ...

Serelaxin, the novel therapy under development for the treatment of acute heart failure, has received a "breakthrough therapy" designation from the FDA, according to Novartis, the company developing the drug. The designation, the FDA explains, "is intended to expedite the development and review of drugs for serious or life-threatening …

Holding back the Dow today is Johnson & Johnson (NYSE: JNJ ), which is lagging the broader Dow index with a 14-cent decline (-0.2%) bringing the stock to $86.85.

The Dow is up 0.59 percent today and stands at 14,999. These stocks are moving the Dow now.

Integra won CE Mark in Europe for its Integra Smart Cervical Solution.

Quest Diagnostics formed an alliance with AT&T; products and services, subsidiaries and affiliates of AT&T; Inc.

* Many see little or negative impact - Gallup survey * Majority of uninsured back Obama's healthcare law By Susan Heavey WASHINGTON, June 27 (Reuters) - A majority of Americans say President Barack Obama's ...

Shares of some top medical devices companies are mixed at 1 p.m.: Allergan fell $.86 or 1.0 percent, to $85.95. Baxter International Inc. rose $.32 or .5 percent, to $70.06. Boston Scientific Corp. rose ...

Shares of some top pharmaceuticals companies are mixed at 1 p.m.: Baxter International Inc. rose $.32 or .5 percent, to $70.06. Bristol-Myers Squibb Co. fell $.22 or .5 percent, to $46.25. Hospira rose ...

Shares of some top health care equipment companies are up at 1 p.m.: Becton, Dickinson & Co. rose $.03 or percent, to $99.19. Covidien rose $.38 or .6 percent, to $62.78. Patterson rose $.53 or 1.4 percent, ...

Shares of some top biotechnology companies are mixed at 1 p.m.: Amgen Inc. fell $.60 or .6 percent, to $99.00. Biogen Idec rose $.11 or .1 percent, to $208.54. Celgene Corp. rose $.10 or .1 percent, to ...

Cadila Healthcare Ltd. a generic- drug maker based in Ahmedabad, India, was sued by Alpex Pharma SA for infringing a U.S. patent for the obesity drug Suprenza.

CNBC's Seema Mody reports on 4 companies listing on the Nasdaq. HD Supply, CDW, Esperion and NanoString are open for trading.

Good governance means more than ensuring efficiency and profitability; it demands that systems be in place to ensure compliance with the law.

By Yasmeen Abutaleb WASHINGTON, June 27 (Reuters) - The U.S. Supreme Court's ruling on Wednesday that same-sex couples are eligible for federal benefits will mean more gays and lesbians can reap the benefits ...

Royalty Pharma, whose $6.7 billion takeover bid for Elan Corp. lapsed this month, is exploring whether to make another bid for the company with a partner, according to four people with knowledge of the ...

CDW's stock climbed Thursday in the information technology company's first day of trading on the Nasdaq. CDW rose $1.48, or 8.7 percent, to $18.48 in late morning trading Thursday after rising as high ...

The Dow component leading the way higher looks to be Pfizer (NYSE: PFE ), which is sporting a 37-cent gain (+1.3%) bringing the stock to $28.47.

Celgene has joined forces with MorphoSys.

Shares of Peregrine Pharmaceuticals Inc. sank Thursday after the drug developer said it will stop studying a treatment combination involving its potential lung cancer drug bavituximab. THE SPARK: The Tustin, ...

(The following statement was released by the rating agency) Link to Fitch Ratings' Report: Hospitals’Credit Diagnosis (Weak Volume Trend Possible Evidence of Systemic Shifts in Care Delivery) here NEW ...

CDW Opens Up 3.6%, Rises From There

Shares of some top health care equipment companies are up at 10 a.m.: Becton, Dickinson & Co. rose $.07 or .1 percent, to $99.23. Covidien plc rose $.31 or .5 percent, to $62.71. Patterson rose $.22 or ...

Shares of some top pharmaceuticals companies are up at 10 a.m.: Baxter International Inc. rose $.56 or .8 percent, to $70.30. Bristol-Myers Squibb Co. rose $.20 or .4 percent, to $46.67. Hospira rose $.94 ...

Shares of some top medical devices companies are mixed at 10 a.m.: Allergan rose $.44 or .5 percent, to $87.25. Baxter International Inc. rose $.56 or .8 percent, to $70.30. Boston Scientific Corp. rose ...

Being a biotech investor is difficult and full of pitfalls. Not only is there clinical trial risk but there are also regulatory and commercial risks, each of which is significant. One thing that isn't ...

Shares of some top biotechnology companies are up at 10 a.m.: Amgen Inc. rose $.51 or .5 percent, to $100.11. Biogen Idec rose $3.90 or 1.9 percent, to $212.33. Celgene Corp. rose $1.52 or 1.3 percent, ...

Humana (NYSE:HUM) hit a new 52-week high Thursday as it is currently trading at $84.76, above its previous 52-week high of $83.40 with 166,210 shares traded as of 10:05 a.m. ET. Average volume has been ...

AstraZeneca (NYSE:AZN) has been downgraded by TheStreet Ratings from from a buy to hold.

Health Care REIT (NYSE:HCN) has been reiterated by TheStreet Ratings as a hold with a ratings score of C+

Waters Corporation (NYSE:WAT) hit a new 52-week high Thursday as it is currently trading at $100.01, above its previous 52-week high of $99.66 with 10,448 shares traded as of 9:35 a.m. ET. Average volume ...

Isis Pharmaceuticals (Nasdaq:ISIS) hit a new 52-week high Thursday as it is currently trading at $28.51, above its previous 52-week high of $24.04 with 85,707 shares traded as of 9:35 a.m. ET. Average ...

Reinsurance Group of America (NYSE:RGA) hit a new 52-week high Thursday as it is currently trading at $67.72, above its previous 52-week high of $67.55 with 7,328 shares traded as of 9:36 a.m. ET. Average ...

WellPoint (NYSE:WLP) hit a new 52-week high Thursday as it is currently trading at $80.64, above its previous 52-week high of $79.78 with 37,799 shares traded as of 9:36 a.m. ET. Average volume has been ...

UnitedHealth Group (NYSE:UNH) hit a new 52-week high Thursday as it is currently trading at $65.06, above its previous 52-week high of $64.90 with 114,167 shares traded as of 9:35 a.m. ET. Average volume ...

The ex-dividend date for Quest Diagnostics (NYSE:DGX) is tomorrow, June 28, 2013. Owners of shares as of market close today will be eligible for a dividend of 30 cents per share. At a price of $61.62 as ...

Of all the companies that specialize in big data analytics, the real pioneer (at scale) has always been SAS – headquartered in Cary, North Carolina. Earlier today, in a big, bold bet on moving one of the larger needles in healthcare, SAS announced a collaborative effort with drug giant GlaxoSmithKline aimed squarely at …